Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Novel precision technology

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Oct 27, 2022 2:31pm

107 Views

Post# 35053889

RE:RE:RE:RE:Novel precision technology

Because TH-1902 has not been proven to work yet. As has been stated here previously, Big Pharma would rather overpay for something known to work than get a bargain taking a chance on something that may or may not work.

If you get PoC and show that TH-1902 has potentially wide application among many cancerous tumors and that the preclinical work on other payloads also looks promising, that is when the bidding war will kick into gear. We are simply not there yet. But we are pretty close to being there, so hang in there as TH could gof rom being dull to super exciting pretty quickly under the rigth circumstances.

stephanedodier wrote: Lee430,

I am also bullish on THTX but the thing that I dont understand is if I was a big pharma and looking at SORT1 as a potential game changer, maybe I would buy under the radar up to 10% of THTX right now on the open market just to get ahead of a potential buyout ? 10% of $200M is pocket change for Pfizer ? The fact that big pharma are waiting to get a slice of THTX is puzzling me....

Any comment anyone ? Why is any big pharma is not taking a chance on us ... now ?

GLTA